Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

11:37 EDT 1 Oct 2018 |

Intoxication is not the only condition that we could diagnose with breathalyzers. The UK-US company Owlstone Medical has secured €43.1M funding to help commercialize its tech that ‘smells’ cancer in your breath. Owlstone’s breathalyzer kit diagnoses conditions by measuring volatile ...

The post Cancer-Sniffing Diagnostics Company Secures €43.1M Funding appeared first on

Original Article: Cancer-Sniffing Diagnostics Company Secures €43.1M Funding


More From BioPortfolio on "Cancer-Sniffing Diagnostics Company Secures €43.1M Funding"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...